BIO Chair Testifies Before Senate

BIO Chair Testifies Before Senate

BIO’s Chair and CEO of GlycoMimetics, Rachel King, testified before the Senate Committee on Small Business and Entrepreneurship today where she reinforced the need for patent protection incentives to encourage small business innovation. Ms. King also encouraged Congress to address weaknesses in the United States Patent and Trademark Office’s Inter Partes Review (IRP) system that allows abuses perpetrated against legitimate patent holders. Read her full testimony.

BIO’s Chair and CEO of GlycoMimetics, Rachel King

BIO’s Chair and CEO of GlycoMimetics, Rachel King

You can read more about BIO’s position on patent reform in our statement of support for the recently introduced STRONG Patents Act of 2015

Filed under: Patently BIOtech, Public Policy, , , ,